Publications

  1. Herrmann J, Lopez-Fernandez T, Lyon AR. The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology. Eur Heart J. 2023 Jan 2 Epub 2023 Jan 02
    View PubMed
  2. Lopez-Fernandez T, Lyon AR, Herrmann J. 2022 ESC Guidelines on cardio-oncology: how can we improve the cardiovascular health of patients with cancer and cancer survivors? Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15; 9 (1):4-5
    View PubMed
  3. Marell PS, Vierkant RA, Olson JE, Herrmann J, Larson N, LeBrasseur NK, D'Andre SD, Cheville AL, Barksdale T, Loprinzi CL, Couch F, Ruddy KJ. Factors Associated With Physical Activity Levels in Patients With Breast Cancer. Oncologist. 2022 Oct 1; 27 (10):e811-e814
    View PubMed
  4. Lyon AR , Lopez-Fernandez T , Couch LS , Asteggiano R , Aznar MC , Bergler-Klein J , Boriani G , Cardinale D , Cordoba R , Cosyns B , Cutter DJ , De Azambuja E , De Boer RA , Dent SF , Farmakis D , Gevaert SA , Gorog DA , Herrmann J , Lenihan D , Moslehi J , Moura B , Salinger SS , Stephens R , Suter TM , Szmit S , Tamargo J , Thavendiranathan P , Tocchetti CG , Van der Meer P , Van der Pal HJH . 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). European Heart Journal-Cardiovascular Imaging. 2022 Sep 10; 23 (10):E333-465
  5. Rajai N, Ahmad A, Toya T, Sara JD, Herrmann J, Lerman LO, Lerman A. Coronary microvascular dysfunction is an independent predictor of developing cancer in patients with non-obstructive coronary artery disease (NOCAD). Eur J Prev Cardiol. 2022 Aug 22 [Epub ahead of print]
    View PubMed
  6. Zhu M, Chen C, Foster NR, Hartley C, Mounajjed T, Salomao MA, Fruth BF, Beamer SE, Kim Y, Harrington SM, Pitot HC, Sanhueza CT, Feng Y, Herrmann J, McWilliams RR, Lucien F, Huang BQ, Ma WW, Bekaii-Saab TS, Dong H, Wigle D, Ahn DH, Hallemeier CL, Blackmon S, Yoon HH. Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction. Clin Cancer Res. 2022 Jul 15; 28 (14):3021-3031
    View PubMed
  7. Kim JW, Dayah TJ, Javaid A, Monlezun DJ, Balanescu DV, Donisan T, Karimzad K, Hakeem A, Boone DL, Palaskas N, Lopez-Mattei J, Kim PY, Durand JB, Song J, Balanescu SM, Yang EH, Herrmann J, Marmagkiolis K, Toutouzas K, Johnson NP, Iliescu CA. Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease. Medicina (Kaunas). 2022 Jul 1; 58 (7) Epub 2022 July 01
    View PubMed
  8. Totzeck M, Michel L, Lin Y, Herrmann J, Rassaf T. Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies. Eur Heart J. 2022 May 21; 43 (20):1928-1940
    View PubMed
  9. Herrmann J, McCullough KB, Habermann TM. How I treat cardiovascular complications in patients with lymphoid malignancies. Blood. 2022 Mar 10; 139 (10):1501-1516
    View PubMed
  10. Lestuzzi C, Stolfo D, De Paoli A, Banzato A, Buonadonna A, Bidoli E, Tartuferi L, Viel E, De Angelis G, Lonardi S, Innocente R, Berretta M, Bergamo F, Guglielmi A, Sinagra G, Herrmann J. Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise. Oncologist. 2022 Mar 4; 27 (2):e158-e167
    View PubMed
  11. Martinez DS, Noseworthy PA, Akbilgic O, Herrmann J, Ruddy KJ, Hamid A, Maddula R, Singh A, Davis R, Gunturkun F, Jefferies JL, Brown SA. Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography. Am Heart J Plus. 2022 Mar; 15 Epub 2022 Apr 01
    View PubMed
  12. Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, Lopez-Fernandez T, Fradley MG, Ganatra S, Curigliano G, Mitchell JD, Minotti G, Lang NN, Liu JE, Neilan TG, Nohria A, O'Quinn R, Pusic I, Porter C, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J. 2022 Jan 31; 43 (4):280-299
    View PubMed
  13. Herrmann J, Lopez-Fernandez T, Lyon AR. Year in cardiovascular medicine: cardio-oncology 2020-21. Eur Heart J. 2022 Jan 3 Epub 2022 Jan 03
    View PubMed
  14. Banerjee P, Olmsted-Davis EA, Deswal A, Nguyen MT, Koutroumpakis E, Palaskas NL, Lin SH, Kotla S, Reyes-Gibby C, Yeung SJ, Yusuf SW, Yoshimoto M, Kobayashi M, Yu B, Schadler K, Herrmann J, Cooke JP, Jain A, Chini E, Le NT, Abe JI. Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. J Cardiovasc Aging. 2022; 2 Epub 2022 Apr 29
    View PubMed
  15. Balanescu DV, Bloomingdale R, Donisan T, Yang EH, Parwani P, Iliescu C, Herrmann J, Hanson I. Mechanisms of myocardial ischemia in cancer patients: a state-of-the-art review of obstructive versus non-obstructive causes. Reviews in Cardiovascular Medicine. 2022; 23 (7):227
  16. Imanishi M, Cheng H, Kotla S, Deswal A, Le NT, Chini E, Ko KA, Samanthapudi VSK, Lee LL, Herrmann J, Xu X, Reyes-Gibby C, Yeung SJ, Schadler KL, Yusuf SW, Liao Z, Nurieva R, Amir ED, Burks JK, Palaskas NL, Cooke JP, Lin SH, Kobayashi M, Yoshimoto M, Abe JI. Radiation therapy induces immunosenescence mediated by p90RSK. Front Cardiovasc Med. 2022; 9:988713 Epub 2022 Nov 07
    View PubMed
  17. Safdar A, Ahmed T, Liu VY, Addoumieh A, Agha AM, Giza DE, Balanescu DV, Donisan T, Dayah T, Lopez-Mattei JC, Kim PY, Hassan S, Karimzad K, Palaskas N, Tsai JY, Iliescu GD, Yang EH, Herrmann J, Marmagkiolis K, Angelini P, Iliescu CA. Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med. 2022; 9:1019284 Epub 2022 Oct 28
    View PubMed
  18. Tawfiq RK, Boddicker N, Martinez JQ, Cordova S, Mashiul Md, Cerhan J, Herrmann J, Thompson CA, Villarraga HR. Evaluating Diastolic Function by Echocardiography in a Prospective Cohort of Patients with Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL) Who Received Anthracycline-Based Chemotherapy Circulation. 2021; 144(Suppl_1):A10607-A10607.
  19. Goldman A, Maor E, Bomze D, Liu JE, Herrmann J, Fein J, Steingart RM, Mahmood SS, Schaffer WL, Perales MA, Shouval R. Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy. J Am Coll Cardiol. 2021 Nov 2; 78 (18):1800-1813
    View PubMed
  20. Kotla S, Zhang A, Imanishi M, Ko KA, Lin SH, Gi YJ, Moczygemba M, Isgandarova S, Schadler KL, Chung C, Milgrom SA, Banchs J, Yusuf SW, Amaya DN, Guo H, Thomas TN, Shen YH, Deswal A, Herrmann J, Kleinerman ES, Entman ML, Cooke JP, Schifitto G, Maggirwar SB, McBeath E, Gupte AA, Krishnan S, Patel ZS, Yoon Y, Burks JK, Fujiwara K, Brookes PS, Le NT, Hamilton DJ, Abe JI. Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation. Redox Biol. 2021 Nov; 47:102132 Epub 2021 Sept 20
    View PubMed
  21. Wang Y, Lu X, Wang X, Qiu Q, Zhu P, Ma L, Ma X, Herrmann J, Lin X, Wang W, Xu X. atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity. Circ Res. 2021 Oct; 129 (8):e166-e182 Epub 2021 Aug 13
    View PubMed
  22. Mitchell JD, Cehic DA, Morgia M, Bergom C, Toohey J, Guerrero PA, Ferencik M, Kikuchi R, Carver JR, Zaha VG, Alvarez-Cardona JA, Szmit S, Daniele AJ, Lopez-Mattei J, Zhang L, Herrmann J, Nohria A, Lenihan DJ, Dent SF. Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society. JACC CardioOncol. 2021 Sep; 3 (3):360-380 Epub 2021 Sept 21
    View PubMed
  23. Herrmann J, Guo W, Fan X, Rihal C, Lerman A. Reply: Cancer Patient Risk After Coronary Intervention: Words of Caution in Complicated Patients. JACC Cardiovasc Interv 2021 Aug 23; 14 (16):1849
    View PubMed
  24. Tehrani DM, Wang X, Rafique AM, Hayek SS, Herrmann J, Neilan TG, Desai P, Morgans A, Lopez-Mattei J, Parikh RV, Yang EH. Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry. Cardiooncology. 2021 Aug 10; 7 (1):28
    View PubMed
  25. Boddicker NJ, Larson MC, Castellino A, Herrmann J, Inwards DJ, Thanarajasingam G, Maurer MJ, Allmer C, Witzig TE, Nowakowski GS, Habermann TM, Villarraga HR, Slager SL, Cerhan JR, Thompson CA. Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. Am J Hematol. 2021 Aug 1; 96 (8):979-988 Epub 2021 May 27
    View PubMed
  26. Patel SR, Herrmann J, Vierkant RA, Olson JE, Couch FJ, Hazim A, Sloan JA, Loprinzi CL, Ruddy KJ. N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors. J Clin Med. 2021 Jul 27; 10 (15) Epub 2021 July 27
    View PubMed
  27. Guo W, Fan X, Lewis BR, Johnson MP, Rihal CS, Lerman A, Herrmann J. Cancer Patients Have a Higher Risk of Thrombotic and Ischemic Events After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2021 May 24; 14 (10):1094-1105
    View PubMed
  28. Sadler D, Arnold A, Herrmann J, Daniele A, Silva CMPDC, Ghosh AK, Szmit S, Khan RI, Raez L, Blaes A, Brown SA. Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building. Curr Oncol Rep. 2021 Apr 14; 23 (6):64
    View PubMed
  29. van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN. Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients. Circ Res. 2021 Apr 2; 128 (7):1040-1061 Epub 2021 Apr 01
    View PubMed
  30. Ezzeddine FM, Saliba AN, Jain V, Villarraga HR, Herrmann J, Asirvatham SJ, Cha YM. Outcomes of cardiac resynchronization therapy in patients with chemotherapy-induced cardiomyopathy. Pacing Clin Electrophysiol. 2021 Apr; 44 (4):625-632 Epub 2021 Mar 15
    View PubMed
  31. Archibald WJ, Rabe KG, Kabat BF, Herrmann J, Ding W, Kay NE, Kenderian SS, Muchtar E, Leis JF, Wang Y, Chanan-Khan AA, Schwager SM, Koehler AB, Fonder AL, Slager SL, Shanafelt TD, Call TG, Parikh SA. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes. Ann Hematol. 2021 Jan; 100 (1):143-155 Epub 2020 June 01
    View PubMed
  32. Marmagkiolis K, Monlezun DJ, Cilingiroglu M, Grines C, Herrmann J, Toutouzas KP, Ates I, Iliescu C. TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-Regression. Front Cardiovasc Med. 2021; 8:641268 Epub 2021 Aug 04
    View PubMed
  33. Aziz MK, Herrmann J, Marmagkiolis K, Balanescu DV, Donisan T, Pushparaji B, Lin HY, Tomakin G, Hoyt T, Pham M, Dijkstra J, Cilingiroglu M, Lopez-Mattei J, Zaha V, Anderson HV, Feldman MD, Molony DA, Iliescu CA. Coronary Stent Healing in Cancer Patients-An Optical Coherence Tomography Perspective. Front Cardiovasc Med. 2021; 8:665303. Epub 2021 Jun 07.
    View PubMed
  34. Ruddy KJ, Patel SR, Higgins AS, Armenian SH, Herrmann J. Cardiovascular Health during and after Cancer Therapy. Cancers (Basel). 2020 Dec 11; 12 (12)
    View PubMed
  35. Abu Rmilah AA, Lin G, Begna KH, Friedman PA, Herrmann J. Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors. Int J Cancer. 2020 Dec 1; 147 (11):3160-3167 Epub 2020 July 16
    View PubMed
  36. Sadler D, DeCara JM, Herrmann J, Arnold A, Ghosh AK, Abdel-Qadir H, Yang EH, Szmit S, Akhter N, Leja M, Silva CMPDC, Raikhelkar J, Brown SA, Dent S, O'Quinn R, Thuny F, Moudgil R, Raez LE, Okwuosa T, Daniele A, Bauer B, Kondapalli L, Ismail-Khan R, Lax J, Blaes A, Nahleh Z, Elson L, Baldassarre LA, Zaha V, Rao V, Lara DS, Skurka K, Cardio-Oncology International Collaborative Network. Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey. Cardiooncology. 2020 Nov 27; 6 (1):28
    View PubMed
  37. Alvarez-Cardona JA, Ray J, Carver J, Zaha V, Cheng R, Yang E, Mitchell JD, Stockerl-Goldstein K, Kondapalli L, Dent S, Arnold A, Brown SA, Leja M, Barac A, Lenihan DJ, Herrmann J, Cardio-Oncology Leadership Council. Cardio-Oncology Education and Training: JACC Council Perspectives. J Am Coll Cardiol. 2020 Nov 10; 76 (19):2267-2281
    View PubMed
  38. Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, Tocchetti CG, Moslehi JJ, Groarke JD, Bergler-Klein J, Khoo V, Tan LL, Anker MS, von Haehling S, Maack C, Pudil R, Barac A, Thavendiranathan P, Ky B, Neilan TG, Belenkov Y, Rosen SD, Iakobishvili Z, Sverdlov AL, Hajjar LA, Macedo AVS, Manisty C, Ciardiello F, Farmakis D, de Boer RA, Skouri H, Suter TM, Cardinale D, Witteles RM, Fradley MG, Herrmann J, Cornell RF, Wechelaker A, Mauro MJ, Milojkovic D, de Lavallade H, Ruschitzka F, Coats AJS, Seferovic PM, Chioncel O, Thum T, Bauersachs J, Andres MS, Wright DJ, Lopez-Fernandez T, Plummer C, Lenihan D. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail. 2020 Nov; 22 (11):1945-1960 Epub 2020 Aug 06
    View PubMed
  39. Owoyemi I, Vaughan LE, Costello CM, Thongprayoon C, Markovic SN, Herrmann J, Otley CC, Taner T, Mangold AR, Leung N, Herrmann SM, Kukla A. Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis. Cancer. 2020 Nov 1; 126 (21):4780-4787 Epub 2020 Aug 12
    View PubMed
  40. Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, Lopez-Fernandez T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement. CA Cancer J Clin. 2020 Nov; 70 (6):480-504 Epub 2020 Sept 10
    View PubMed
  41. Vallabhajosyula S, Barsness GW, Herrmann J, Anavekar NS, Gulati R, Prasad A. Comparison of Complications and In-Hospital Mortality in Takotsubo (Apical Ballooning/Stress) Cardiomyopathy Versus Acute Myocardial Infarction. Am J Cardiol. 2020 Oct 1; 132:29-35 Epub 2020 July 13
    View PubMed
  42. Ganatra S, Dani SS, Shah S, Asnani A, Neilan TG, Lenihan D, Ky B, Barac A, Hayek SS, Leja M, Herrmann J, Thavendiranathan P, Fradley M, Bang V, Shreyder K, Parikh R, Patel R, Singh A, Brar S, Guha A, Gupta D, Mascari P, Patten RD, Venesy DM, Nohria A, Resnic FS. Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic. Trends Cardiovasc Med. 2020 Aug; 30 (6):315-325 Epub 2020 May 28
    View PubMed
  43. Herrmann J. Vascular toxic effects of cancer therapies. Nat Rev Cardiol. 2020 Aug; 17 (8):503-522 Epub 2020 Mar 26
    View PubMed
  44. Herrmann J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol. 2020 Aug; 17 (8):474-502 Epub 2020 Mar 30
    View PubMed
  45. Brown SA, Ray JC, Herrmann J. Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors. J Cardiovasc Transl Res. 2020 Jun; 13 (3):402-416 Epub 2020 Apr 06
    View PubMed
  46. Taparra K, Lester SC, Harmsen WS, Petersen M, Funk RK, Blanchard MJ, Young P, Herrmann J, Hunzeker A, Schultz H, McCollough C, Tasson A, Leng S, Martenson JA, Whitaker TJ, Williamson E, Laack NN. Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment. Int J Part Ther. 2020 Summer; 7 (1):1-12 Epub 2020 Sept 04
    View PubMed
  47. Gerber Y, Gibbons RJ, Weston SA, Fabbri M, Herrmann J, Manemann SM, Frye RL, Asleh R, Greason K, Killian JM, Roger VL. Coronary Disease Surveillance in the Community: Angiography and Revascularization. J Am Heart Assoc. 2020 Apr 7; 9 (7):e015231 Epub 2020 Apr 02
    View PubMed
  48. Hedayati E, Papakonstantinou A, Gernaat SAM, Altena R, Brand JS, Alfredsson J, Bhoo-Pathy N, Herrmann J, Linde C, Dahlstrom U, Bergh J, Hubbert L. Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study. Eur Heart J Qual Care Clin Outcomes. 2020 Apr 1; 6 (2):147-155
    View PubMed
  49. Toya T, Sara JD, Corban MT, Taher R, Godo S, Herrmann J, Lerman LO, Lerman A. Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer. Eur J Prev Cardiol. 2020 Apr; 27 (6):608-618 Epub 2019 Oct 31
    View PubMed
  50. Ruddy KJ, Sangaralingham LR, Van Houten H, Nowsheen S, Sandhu N, Moslehi J, Neuman H, Jemal A, Haddad TC, Blaes AH, Villarraga HR, Thompson C, Shah ND, Herrmann J. Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy. Circ Cardiovasc Qual Outcomes. 2020 Mar; 13 (3):e005984 Epub 2020 Feb 28
    View PubMed
  51. Lester SC, Taparra K, Petersen MM, Funk RK, Blanchard MJ, Young PM, Herrmann J, Hunzeker AE, Schultz HL, McCollough C, Tasson AM, Leng S, Martenson JA, Deisher AJ, Whitaker TJ, Williamson EE, Laack NN. Electrocardiogram-Gated Computed Tomography with Coronary Angiography for Cardiac Substructure Delineation and Sparing in Patients with Mediastinal Lymphomas Treated with Radiation Therapy. Pract Radiat Oncol. 2020 Mar - Apr; 10 (2):104-111 Epub 2019 Nov 26
    View PubMed
  52. Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020 Feb; 31 (2):171-190
    View PubMed
  53. Manohar S, Ghamrawi R, Chengappa M, Goksu BNB, Kottschade L, Finnes H, Dronca R, Leventakos K, Herrmann J, Herrmann SM. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge. Kidney360. 2020 Jan 30; 1 (1):16-24 Epub 2020 Jan 07
    View PubMed
  54. Herrmann J, Villarraga HR. Utilization of Cardiac Surveillance TEsts in Survivors of Breast Cancer and Lymphoma After Antracycline-Based Chemotherapy Circulation Journal. 2020.
  55. Ma X, Zhu P, Ding Y, Zhang H, Qiu Q, Dvornikov AV, Wang Z, Kim M, Wang Y, Lowerison M, Yu Y, Norton N, Herrmann J, Ekker SC, Hsiai TK, Lin X, Xu X. Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity. Sci Adv. 2020 Jan; 6 (5):eaay2939 Epub 2020 Jan 29
    View PubMed
  56. Abe JI, Yusuf SW, Deswal A, Herrmann J. Cardio-Oncology: Learning From the Old, Applying to the New. Front Cardiovasc Med. 2020; 7:601893 Epub 2020 Nov 25
    View PubMed
  57. Barham W, Guo R, Park SS, Herrmann J, Dong H, Yan Y. Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy. Front Immunol. 2020; 11:561083 Epub 2021 Feb 02
    View PubMed
  58. Herrmann J. From trends to transformation: where cardio-oncology is to make a difference. Eur Heart J 2019 Dec 21; 40 (48):3898-3900
    View PubMed
  59. Ruddy KJ, Sangaralingham LR, Van HK, Nowsheen S, Sandhu NP, Moslehi Javid, Neuman Heather, Jemal Ahmedin, Haddad TC, Blaes Anne, Villarraga HR, Thompson CA, Shah ND, Herrmann J. Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy Circulation: Cardiovascular Quality and Outcomes. 2019. Epub 2019 Dec 23.
  60. Lenihan DJ, Fradley MG, Dent S, Brezden-Masley C, Carver J, Filho RK, Neilan TG, Blaes A, Melloni C, Herrmann J, Armenian S, Thavendiranathan P, Armstrong GT, Ky B, Hajjar L. Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology. JACC CardioOncol. 2019 Dec; 1 (2):256-272 Epub 2019 Dec 17
    View PubMed
  61. Herrmann J. Common Vascular Toxicities of Cancer Therapies. Cardiol Clin. 2019 Nov; 37 (4):365-384 Epub 2019 Aug 26
    View PubMed
  62. Jentzer JC, van Diepen S, Barsness GW, Katz JN, Wiley BM, Bennett CE, Mankad SV, Sinak LJ, Best PJ, Herrmann J, Jaffe AS, Murphy JG, Morrow DA, Wright RS, Bell MR, Anavekar NS. Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population. Am Heart J. 2019 Sep; 215:12-19 Epub 2019 June 04
    View PubMed
  63. Jiang X, Wang F, Wang Y, Gistera A, Roy J, Paulsson-Berne G, Hedin U, Lerman A, Hansson GK, Herrmann J, Yan ZQ. Inflammasome-Driven Interleukin-1alpha and Interleukin-1beta Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity. JACC Basic Transl Sci. 2019 Jun; 4 (3):304-317 Epub 2019 June 24
    View PubMed
  64. Zhang D, Guo W, Al-Hijji MA, El Sabbagh A, Lewis BR, Greason K, Sandhu GS, Eleid MF, Holmes DR, Herrmann J. Outcomes of Patients With Severe Symptomatic Aortic Valve Stenosis After Chest Radiation: Transcatheter Versus Surgical Aortic Valve Replacement. J Am Heart Assoc. 2019 May 21; 8 (10):e012110
    View PubMed
  65. Layoun ME, Yang EH, Herrmann J, Iliescu CA, Lopez-Mattei JC, Marmagkiolis K, Budoff MJ, Ferencik M. Applications of Cardiac Computed Tomography in the Cardio-Oncology Population. Curr Treat Options Oncol. 2019 May 6; 20 (6):47 Epub 2019 May 06
    View PubMed
  66. Balanescu DV, Donisan T, Dayah T, Palaskas N, Lopez-Mattei J, Kim P, Pinnix CC, Moudgil R, Balanescu SM, Herrmann J, Cilingiroglu M, Marmagkiolis K, Iliescu C. Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography. Int J Cardiovasc Imaging. 2019 May; 35 (5):759-760 Epub 2019 Feb 13
    View PubMed
  67. Jentzer JC, Herrmann J, Prasad A, Barsness GW, Bell MR. Utility and Challenges of an Early Invasive Strategy in Patients Resuscitated From Out-of-Hospital Cardiac Arrest. JACC Cardiovasc Interv. 2019 Apr 22; 12 (8):697-708
    View PubMed
  68. Ohad O, Herrmann J. Erratum to arterial events in cancer patients-the case of acute coronary thrombosis. J Thorac Dis. 2019 Apr; 11 (4):E70
    View PubMed
  69. Campia U, Moslehi JJ, Amiri-Kordestani L, Barac A, Beckman JA, Chism DD, Cohen P, Groarke JD, Herrmann J, Reilly CM, Weintraub NL. Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association. Circulation. 2019 Mar 26; 139 (13):e579-e602
    View PubMed
  70. Park JY, Guo W, Al-Hijji M, El Sabbagh A, Begna KH, Habermann TM, Witzig TE, Lewis BR, Lerman A, Herrmann J. Acute coronary syndromes in patients with active hematologic malignancies - Incidence, management, and outcomes. Int J Cardiol. 2019 Jan 15; 275:6-12 Epub 2018 Oct 05
    View PubMed
  71. Manohar S, Kompotiatis P, Thongprayoon C, Cheungpasitporn W, Herrmann J, Herrmann SM. Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis. Nephrol Dial Transplant. 2019 Jan 1; 34 (1):108-117
    View PubMed
  72. Herrmann J. Detecting cardiotoxicity in cancer patients receiving vegf inhibitors Oncology (08909091). 2019; 33 (2):75-7
  73. Khorramirouz R, Corban MT, Yang SW, Lewis BR, Bois J, Foley T, Lerman LO, Herrmann J, Oh JK, Lerman A. Microvascular obstruction in non-infarct related coronary arteries is an independent predictor of major adverse cardiovascular events in patients with ST segment-elevation myocardial infarction. Int J Cardiol. 2018 Dec 15; 273:22-28 Epub 2018 Aug 16
    View PubMed
  74. Oren O, Herrmann J. Arterial events in cancer patients-the case of acute coronary thrombosis. J Thorac Dis. 2018 Dec; 10 (Suppl 35):S4367-S4385
    View PubMed
  75. Arciniegas Calle MC, Sandhu NP, Xia H, Cha SS, Pellikka PA, Ye Z, Herrmann J, Villarraga HR. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer. 2018 Oct 25; 18 (1):1037
    View PubMed
  76. Herrmann J, Loprinzi C, Ruddy K. Building a Cardio-Onco-Hematology Program. Curr Oncol Rep. 2018 Sep 10; 20 (10):81 Epub 2018 Sept 10
    View PubMed
  77. Wang F, Zhang S, Vuckovic I, Jeon R, Lerman A, Folmes CD, Dzeja PP, Herrmann J. Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation. Cell Metab. 2018 Sep 4; 28 (3):463-475.e4
    View PubMed
  78. Corban MT, Prasad A, Nesbitt L, Loeffler D, Herrmann J, Lerman LO, Lerman A. Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans. J Am Heart Assoc. 2018 Aug 7; 7 (15):e009881
    View PubMed
  79. Nowsheen S, Aziz K, Park JY, Lerman A, Villarraga HR, Ruddy KJ, Herrmann J. Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction. J Am Heart Assoc. 2018 Aug 7; 7 (15):e008637
    View PubMed
  80. Donisan T, Balanescu DV, Lopez-Mattei JC, Kim P, Leja MJ, Banchs J, Marmagkiolis K, Herrmann J, Gregoric I, Durand JB, Iliescu CA. In Search of a Less Invasive Approach to Cardiac Tumor Diagnosis: Multimodality Imaging Assessment and Biopsy. JACC Cardiovasc Imaging. 2018 Aug; 11(8):1191-1195.
    View PubMed
  81. Chari A, Stewart AK, Russell SD, Moreau P, Herrmann J, Banchs J, Hajek R, Groarke J, Lyon AR, Batty GN, Ro S, Huang M, Iskander KS, Lenihan D. Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials. Blood Adv. 2018 Jul 10; 2 (13):1633-1644
    View PubMed
  82. Touyz RM, Herrmann SMS, Herrmann J. Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. J Am Soc Hypertens. 2018 Jun; 12 (6):409-425 Epub 2018 Mar 21
    View PubMed
  83. Tuzovic M, Herrmann J, Iliescu C, Marmagkiolis K, Ziaeian B, Yang EH. Arterial Thrombosis in Patients with Cancer. Curr Treat Options Cardiovasc Med. 2018 Apr 7; 20 (5):40 Epub 2018 Apr 07
    View PubMed
  84. Wang F, Zhang S, Jeon R, Vuckovic I, Jiang X, Lerman A, Folmes CD, Dzeja PD, Herrmann J. Interferon Gamma Induces Reversible Metabolic Reprogramming of M1 Macrophages to Sustain Cell Viability and Pro-Inflammatory Activity. EBioMedicine. 2018 Apr; 30:303-316 Epub 2018 Feb 13
    View PubMed
  85. Squires RW, Shultz AM, Herrmann J. Exercise Training and Cardiovascular Health in Cancer Patients. Curr Oncol Rep. 2018 Mar 10; 20(3):27.
    View PubMed
  86. Larsen CM, Villarraga HR, Begna KH, Litzow MR, Al-Kali A, Herrmann J. Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia. Leuk Lymphoma 2018 Jan; 59 (1):229-232 Epub 2017 June 08
    View PubMed
  87. Fender EA, Chandrashekar P, Liang JJ, Dhar PR, Sio TT, Stulak JM, Lennon RJ, Slusser JP, Ashman JB, Miller RC, Herrmann J, Prasad A, Sandhu GS. Coronary artery bypass grafting in patients treated with thoracic radiation: a case-control study. Open Heart. 2018; 5 (1):e000766 Epub 2018 Feb 14
    View PubMed
  88. Sara JD, Kaur J, Khodadadi R, Rehman M, Lobo R, Chakrabarti S, Herrmann J, Lerman A, Grothey A. 5-fluorouracil and cardiotoxicity: a review. Ther Adv Med Oncol. 2018; 10:1758835918780140 Epub 2018 June 18
    View PubMed
  89. Touyz RM, Herrmann J. Cardiotoxicity with vascular endothelial growth factor inhibitor therapy. NPJ Precis Oncol. 2018; 2:13 Epub 2018 May 08
    View PubMed
  90. Nowsheen S, Viscuse PV, O'Sullivan CC, Sandhu NP, Haddad TC, Blaes A, Klemp J, Nhola L, Herrmann J, Ruddy KJ. Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast Cancer. Curr Breast Cancer Rep. 2017 Sep; 9 (3):173-182 Epub 2017 July 14
    View PubMed
  91. Sara JDS, Prasad M, Zhang M, Lennon RJ, Herrmann J, Lerman LO, Lerman A. High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease. Am Heart J. 2017 Aug; 190:1-11.
    View PubMed
  92. Touyz RM, Lang NN, Herrmann J, van den Meiracker AH, Danser AHJ. Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition. Hypertension. 2017 Aug; 70 (2):220-226 Epub 2017 June 19
    View PubMed
  93. Fender EA, Liang JJ, Sio TT, Stulak JM, Lennon RJ, Slusser JP, Ashman JB, Miller RC, Herrmann J, Prasad A, Sandhu GS. Percutaneous revascularization in patients treated with thoracic radiation for cancer. Am Heart J. 2017 May; 187:98-103 Epub 2017 Feb 20
    View PubMed
  94. Snipelisky D, Park JY, Lerman A, Mulvagh S, Lin G, Pereira N, Rodriguez-Porcel M, Villarraga HR, Herrmann J. How to Develop a Cardio-Oncology Clinic. Heart Fail Clin. 2017 Apr; 13 (2):347-359
    View PubMed
  95. Park JY, Lerman A, Herrmann J. Use of fractional flow reserve in patients with coronary artery disease: The right choice for the right outcome. Trends Cardiovasc Med. 2017 Feb; 27 (2):106-120 Epub 2016 June 29
    View PubMed
  96. Jouni H, Aubry MC, Lacy MQ, Vincent Rajkumar S, Kumar SK, Frye RL, Herrmann J. Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors. Am J Hematol. 2017 Feb; 92 (2):220-221
    View PubMed
  97. Prasad M, Matteson EL, Herrmann J, Gulati R, Rihal CS, Lerman LO, Lerman A. Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women. Hypertension. 2017 Feb; 69 (2):236-242 Epub 2016 Dec 19
    View PubMed
  98. Mazur M, Wang F, Hodge DO, Siontis BL, Beinborn DS, Villarraga HR, Lerman A, Friedman PA, Herrmann J. Burden of Cardiac Arrhythmias in Patients With Anthracycline-Related Cardiomyopathy. JACC Clin Electrophysiol. 2017 Feb; 3 (2):139-150 Epub 2016 Sept 28
    View PubMed
  99. Brown SA, Nhola L, Herrmann J. Cardiovascular Toxicities of Small Molecule Tyrosine Kinase Inhibitors: An Opportunity for Systems-Based Approaches. Clin Pharmacol Ther. 2017 Jan; 101 (1):65-80 Epub 2016 Nov 26
    View PubMed
  100. Mankad R, Herrmann J. Cardiac tumors: echo assessment. Echo Res Pract. 2016 Dec; 3 (4):R65-R77 Epub 2016 Sept 06
    View PubMed
  101. Wang F, Gulati R, Lennon RJ, Lewis BR, Park J, Sandhu GS, Wright RS, Lerman A, Herrmann J. Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Mayo Clin Proc. 2016 Dec; 91 (12):1680-1692
    View PubMed
  102. Park KH, Sun T, Diez-Delhoyo F, Liu Z, Yang SW, Lennon RJ, Herrmann J, Gulati R, Rodriguez-Porcel M, Lerman LO, Lerman A. Association between coronary microvascular function and the vasa vasorum in patients with early coronary artery disease. Atherosclerosis. 2016 Oct; 253:144-149 Epub 2016 Aug 26
    View PubMed
  103. Liu Z, Matsuzawa Y, Herrmann J, Li J, Lennon RJ, Crusan DJ, Kwon TG, Zhang M, Sun T, Yang S, Gulati R, Bell MR, Lerman LO, Lerman A. Relation between fractional flow reserve value of coronary lesions with deferred revascularization and cardiovascular outcomes in non-diabetic and diabetic patients. Int J Cardiol. 2016 Sep 15; 219:56-62. Epub 2016 May 16.
    View PubMed
  104. Herrmann J. Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System? Curr Oncol Rep. 2016 Jun; 18 (6):33
    View PubMed
  105. Barros-Gomes S, Herrmann J, Mulvagh SL, Lerman A, Lin G, Villarraga HR. Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic. Cardiooncology. 2016 Apr 19; 2 (1):5
    View PubMed
  106. Iliescu C, Grines CL, Herrmann J, Yang EH, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Marmagkiolis K. SCAI expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencionista). Catheter Cardiovasc Interv. 2016 Apr; 87: (5)895-9.
    View PubMed
  107. Iliescu CA, Grines CL, Herrmann J, Yang EH, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas KP, Leesar MA, Marmagkiolis K. SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista). Catheter Cardiovasc Interv. 2016 Apr; 87 (5):E202-23 Epub 2016 Jan 12
    View PubMed
  108. Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Grines CL, Marmagkiolis K. Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue. Circulation. 2016 Mar 29; 133 (13):1272-89
    View PubMed
  109. Brown SA, Sandhu N, Herrmann J. Systems biology approaches to adverse drug effects: the example of cardio-oncology. Nat Rev Clin Oncol. 2015 Dec; 12 (12):718-31 Epub 2015 Oct 13
    View PubMed
  110. Bordun KA, Premecz S, daSilva M, Mandal S, Goyal V, Glavinovic T, Cheung M, Cheung D, White CW, Chaudhary R, Freed DH, Villarraga HR, Herrmann J, Kohli M, Ravandi A, Thliveris J, Pitz M, Singal PK, Mulvagh S, Jassal DS. The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity. Am J Physiol Heart Circ Physiol. 2015 Aug 15; 309 (4):H692-701 Epub 2015 June 19
    View PubMed
  111. Barac A, Murtagh G, Carver JR, Chen MH, Freeman AM, Herrmann J, Iliescu C, Ky B, Mayer EL, Okwuosa TM, Plana JC, Ryan TD, Rzeszut AK, Douglas PS. Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level. J Am Coll Cardiol. 2015 Jun 30; 65 (25):2739-46
    View PubMed
  112. Yang EH, Watson KE, Herrmann J. Should vascular effects of newer treatments be addressed more completely? Future Oncol. 2015; 11: (14)1995-8.
    View PubMed
  113. Herrmann J, Yang EH. Should the 'echo guidelines' be followed in cancer patients? Future Oncol. 2015; 11: (14)2021-5.
    View PubMed
  114. Petek BJ, Greenman C, Herrmann J, Ewer MS, Jones RL. Cardio-oncology: an ongoing evolution. Future Oncol. 2015; 11: (14)2059-66.
    View PubMed
  115. Wang F, Lerman A, Herrmann J. Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease. Am J Cardiovasc Dis. 2015; 5 (1):83-100 Epub 2015 Mar 10
    View PubMed
  116. Herrmann J, Herrmann SM, Haddad TC. New-onset heart failure in association with severe hypertension during trastuzumab therapy. Mayo Clin Proc. 2014 Dec; 89: (12)1734-9.
    View PubMed
  117. Herrmann J, Lerman A. An update on cardio-oncology. Trends Cardiovasc Med. 2014 Oct; 24 (7):285-95 Epub 2014 July 22
    View PubMed
  118. Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc. 2014 Sep; 89 (9):1287-306
    View PubMed
  119. Herrmann J, Lennon RJ, Jaffe AS, Holmes DR Jr, Rihal CS, Prasad A. Defining the optimal cardiac troponin T threshold for predicting death caused by periprocedural myocardial infarction after percutaneous coronary intervention. Circ Cardiovasc Interv. 2014 Aug; 7(4):533-42. Epub 2014 Jul 22.
    View PubMed
  120. Herrmann J, Gersh BJ, Goldfinger JZ, Witzenbichler B, Guagliumi G, Dudek D, Kornowski R, Brener SJ, Parise H, Fahy M, McAndrew TC, Stone GW, Mehran R. Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). Am J Cardiol. 2014 Jul 1; 114(1):9-16. Epub 2014 Apr 16.
    View PubMed
  121. Villarraga HR, Herrmann J, Nkomo VT. Cardio-oncology: role of echocardiography. Prog Cardiovasc Dis. 2014 Jul-Aug; 57 (1):10-8 Epub 2014 May 20
    View PubMed
  122. Miller TD, Askew JW, Herrmann J. Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators? Curr Cardiol Rep. 2014 Apr; 16 (4):465
    View PubMed
  123. Widmer RJ, Chung WY, Herrmann J, Jordan KL, Lerman LO, Lerman A. The association between circulating microRNA levels and coronary endothelial function. PLoS One. 2014; 9 (10):e109650 Epub 2014 Oct 13
    View PubMed
  124. Yoshino S, Cassar A, Matsuo Y, Herrmann J, Gulati R, Prasad A, Lennon RJ, Lerman LO, Lerman A. Fractional flow reserve with dobutamine challenge and coronary microvascular endothelial dysfunction in symptomatic myocardial bridging. Circ J. 2014; 78 (3):685-92 Epub 2014 Jan 24
    View PubMed
  125. Li J, Rihal CS, Matsuo Y, Elrashidi MY, Flammer AJ, Lee MS, Cassar A, Lennon RJ, Herrmann J, Bell MR, Holmes DR, Bresnahan JF, Hua Q, Lerman LO, Lerman A. Sex-related differences in fractional flow reserve-guided treatment. Circ Cardiovasc Interv. 2013 Dec; 6 (6):662-70 Epub 2013 Oct 22
    View PubMed
  126. Yla-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jauhiainen S, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PWJC, Waltenberger J, Weber C, Tokgozoglu L. Stabilization of atherosclerotic plaques: an update. Eur Heart J. 2013 Nov; 34(42):3251-8.
    View PubMed
  127. Matsuo Y, Cassar A, Li J, Flammer AJ, Choi BJ, Herrmann J, Gulati R, Lennon RJ, Kang SJ, Maehara A, Kitabata H, Akasaka T, Lerman LO, Kushwaha SS, Lerman A. Repeated episodes of thrombosis as a potential mechanism of plaque progression in cardiac allograft vasculopathy. Eur Heart J. 2013 Oct; 34 (37):2905-15 Epub 2013 June 19
    View PubMed
  128. Cassar A, Matsuo Y, Herrmann J, Li J, Lennon RJ, Gulati R, Lerman LO, Kushwaha SS, Lerman A. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. Eur Heart J. 2013 Sep; 34 (33):2610-7 Epub 2013 June 25
    View PubMed
  129. Herrmann J, Wohlert C, Saguner AM, Flores A, Nesbitt LL, Chade A, Lerman LO, Lerman A. Primary proteasome inhibition results in cardiac dysfunction. Eur J Heart Fail. 2013 Jun; 15 (6):614-23 Epub 2013 Apr 24
    View PubMed
  130. Ferri N, Siegl P, Corsini A, Herrmann J, Lerman A, Benghozi R. Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. Pharmacol Ther. 2013 Jun; 138(3):470-84. Epub 2013 Mar 15.
    View PubMed
  131. Widmer RJ, Flammer AJ, Herrmann J, Rodriguez-Porcel M, Wan J, Cohen P, Lerman LO, Lerman A. Circulating humanin levels are associated with preserved coronary endothelial function. Am J Physiol Heart Circ Physiol. 2013 Feb 1; 304 (3):H393-7 Epub 2012 Dec 07
    View PubMed
  132. Herrmann J, Lennon RJ, Barsness GW, Sandhu GS, Gulati R, Best PJ, Sorajja P, Bresnahan JF, Mathew V, Bell MR, Prasad A. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice. Circ Cardiovasc Interv. 2012 Dec; 5(6):783-90. Epub 2012 Dec 04.
    View PubMed
  133. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J. 2012 Nov; 33 (22):2771-2782b Epub 2012 Aug 22
    View PubMed
  134. Jouni H, Morice WG, Rajkumar SV, Herrmann J. A classic case of amyloid cardiomyopathy. BMJ Case Rep. 2012 Oct 9; 2012 Epub 2012 Oct 09
    View PubMed
  135. Zacharias DG, Kim SG, Massat AE, Bachar AR, Oh YK, Herrmann J, Rodriguez-Porcel M, Cohen P, Lerman LO, Lerman A. Humanin, a cytoprotective peptide, is expressed in carotid atherosclerotic [corrected] plaques in humans. PLoS One. 2012; 7 (2):e31065 Epub 2012 Feb 06
    View PubMed
  136. Powell SR, Herrmann J, Lerman A, Patterson C, Wang X. The ubiquitin-proteasome system and cardiovascular disease. Prog Mol Biol Transl Sci. 2012; 109:295-346.
    View PubMed
  137. Yla-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW, Waltenberger J, Weber C, Tokgozoglu L. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Thromb Haemost. 2011 Jul; 106(1):1-19. Epub 2011 Jun 14.
    View PubMed
  138. Mannheim D, Herrmann J, Bonetti PO, Lavi R, Lerman LO, Lerman A. Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect. Atherosclerosis. 2011 Jun; 216 (2):283-91 Epub 2011 Feb 24
    View PubMed
  139. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 2011 Feb 3; 364 (5):453-64
    View PubMed
  140. Herrmann J, Lerman LO, Lerman A. On to the road to degradation: atherosclerosis and the proteasome. Cardiovasc Res. 2010 Jan 15; 85 (2):291-302 Epub 2009 Oct 08
    View PubMed
  141. Herrmann J, Mannheim D, Wohlert C, Versari D, Meyer FB, McConnell JP, Gossl M, Lerman LO, Lerman A. Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome. Eur Heart J. 2009 Dec; 30 (23):2930-8 Epub 2009 Aug 17
    View PubMed
  142. Gossl M, Herrmann J, Tang H, Versari D, Galili O, Mannheim D, Rajkumar SV, Lerman LO, Lerman A. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res Cardiol. 2009 Nov; 104 (6):695-706 Epub 2009 May 21
    View PubMed
  143. Sattler KJ, Herrmann J, Yun S, Lehmann N, Wang Z, Heusch G, Sack S, Erbel R, Levkau B. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention. Eur Heart J. 2009 Aug; 30(15):1894-902. Epub 2009 May 27.
    View PubMed
  144. Woodrum DA, Herrmann J, Lerman A, Romano AJ, Lerman LO, Ehman RL. Phase-contrast MRI-based elastography technique detects early hypertensive changes in ex vivo porcine aortic wall. J Magn Reson Imaging. 2009 Mar; 29 (3):583-7
    View PubMed
  145. Herrmann J, Lerman A. The endothelium - the cardiovascular health barometer. Herz. 2008 Jul; 33 (5):343-53 Epub 2008 Sept 05
    View PubMed
  146. Hildebrandt HA, Gossl M, Mannheim D, Versari D, Herrmann J, Spendlove D, Bajanowski T, Malyar NM, Erbel R, Lerman LO, Lerman A. Differential distribution of vasa vasorum in different vascular beds in humans. Atherosclerosis. 2008 Jul; 199: (1)47-54.
    View PubMed
  147. Lavi S, Herrmann J, Lavi R, McConnell JP, Lerman LO, Lerman A. Role of lipoprotein-associated phospholipase A2 in atherosclerosis. Curr Atheroscler Rep. 2008 Jun; 10 (3):230-5
    View PubMed
  148. Herrmann J, Soares SM, Lerman LO, Lerman A. Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease. J Am Coll Cardiol. 2008 May 27; 51: (21)2003-10.
    View PubMed
  149. Mannheim D, Herrmann J, Versari D, Gossl M, Meyer FB, McConnell JP, Lerman LO, Lerman A. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. Stroke. 2008 May; 39 (5):1448-55 Epub 2008 Mar 20
    View PubMed
  150. Herrmann J, Saguner AM, Versari D, Peterson TE, Chade A, Olson M, Lerman LO, Lerman A. Chronic proteasome inhibition contributes to coronary atherosclerosis. Circ Res. 2007 Oct 26; 101(9):865-74. Epub 2007 Sep 06.
    View PubMed
  151. Herrmann J, Lerman LO, Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ Res. 2007 May 11; 100 (9):1276-91
    View PubMed
  152. Lerman A, Holmes DR, Herrmann J, Gersh BJ. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur Heart J. 2007 Apr; 28 (7):788-97 Epub 2007 Mar 08
    View PubMed
  153. Herrmann J, Versari D, Goessl M, Mannheim D, Sattler K, Meyer FB, Ciechanover A, Lerman LO, Lerman A. Imbalance in the ubiquitin-proteasome system activity in human symptomatic carotid disease. Arterioscler Thromb Vasc Biol..;26()2132-9..
  154. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, von Wnuck Lipinski K, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation. 2006 Sep 26; 114(13):1403-9. Epub 2006 Sep 18.
    View PubMed
  155. Herrmann J, Lerman LO, Mukhopadhyay D, Napoli C, Lerman A. Angiogenesis in atherogenesis. Arterioscler Thromb Vasc Biol. 2006 Sep; 26 (9):1948-57 Epub 2006 June 22
    View PubMed
  156. Versari D, Herrmann J, Gossl M, Mannheim D, Sattler K, Meyer FB, Lerman LO, Lerman A. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2006 Sep; 26 (9):2132-9 Epub 2006 June 15
    View PubMed
  157. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J. 2005 Dec; 26 (23):2493-519 Epub 2005 Sept 21
    View PubMed
  158. Alegria JR, Herrmann J, Holmes DR Jr, Lerman A, Rihal CS. Myocardial bridging. Eur Heart J. 2005 Jun; 26 (12):1159-68 Epub 2005 Mar 11
    View PubMed
  159. Chade AR, Herrmann J, Zhu X, Krier JD, Lerman A, Lerman LO. Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia. J Am Soc Nephrol. 2005 Apr; 16 (4):1005-12 Epub 2005 Feb 16
    View PubMed
  160. Galili O, Sattler KJ, Herrmann J, Woodrum J, Olson M, Lerman LO, Lerman A. Experimental hypercholesterolemia differentially affects adventitial vasa vasorum and vessel structure of the left internal thoracic and coronary arteries. J Thorac Cardiovasc Surg. 2005 Apr; 129(4):767-72.
    View PubMed
  161. Herrmann J, Samee S, Chade A, Rodriguez Porcel M, Lerman LO, Lerman A. Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling. Arterioscler Thromb Vasc Biol. 2005 Feb; 25(2):447-53. Epub 2004 Dec 9
    View PubMed
  162. Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system--micro target for macro intervention? Int J Cardiovasc Intervent. 2005; 7: (1)5-13.
    View PubMed
  163. Herrmann J, Higano ST, Lenon RJ, Rihal CS, Lerman A. Myocardial bridging is associated with alteration in coronary vasoreactivity. Eur Heart J. 2004 Dec; 25(23):2134-42.
    View PubMed
  164. Galili O, Herrmann J, Woodrum J, Sattler KJ, Lerman LO, Lerman A. Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg. 2004 Sep; 40: (3)529-35.
    View PubMed
  165. Chade AR, Rodriguez-Porcel M, Herrmann J, Zhu X, Zhu X, Grande JP, Napoli C, Lerman A, Lerman LO. Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol. 2004 Apr; 15 (4):958-66
    View PubMed
  166. Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovasc Res. 2004 Jan 1; 61 (1):11-21
    View PubMed
  167. Chade AR, Rodriguez-Porcel M, Herrmann J, Krier JD, Zhu X, Lerman A, Lerman LO. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension. 2003 Oct; 42: (4)605-12.
    View PubMed
  168. Chade AR, Best PJ, Rodriguez-Porcel M, Herrmann J, Zhu X, Sawamura T, Napoli C, Lerman A, Lerman LO. Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. Kidney Int. 2003 Sep; 64 (3):962-9
    View PubMed
  169. von Birgelen C, Mintz GS, Eggebrecht H, Herrmann J, Jasper M, Brinkhoff J, Neumann T, Bose D, Baumgart D, Schmermund A, Wieneke H, Haude M, Erbel R. Preintervention arterial remodeling affects vessel stretch and plaque extrusion during coronary stent deployment as demonstrated by three-dimensional intravascular ultrasound. Am J Cardiol. 2003 Jul 15; 92(2):130-5.
    View PubMed
  170. Herrmann J, Gulati R, Napoli C, Woodrum JE, Lerman LO, Rodriguez-Porcel M, Sica V, Simari RD, Ciechanover A, Lerman A. Oxidative stress-related increase in ubiquitination in early coronary atherogenesis. FASEB J. 2003 Jul; 17(10).
  171. de Nigris F, Sica V, Herrmann J, Condorelli G, Chade AR, Tajana G, Lerman A, Lerman LO, Napoli C. c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle. 2003 Jul-Aug; 2(4):325-8.
    View PubMed
  172. von Birgelen C, Mintz GS, Sieling C, Bose D, Eggebrecht H, Baumgart D, Neumann T, Herrmann J, Haude M, Erbel R. Relation between plaque composition and vascular remodeling in coronary lesions with different degrees of lumen narrowing as assessed with three-dimensional intravascular ultrasound in patients with stable angina pectoris. Am J Cardiol. 2003 May 1; 91(9):1103-7.
    View PubMed
  173. Rodriguez-Porcel M, Lerman LO, Herrmann J, Sawamura T, Napoli C, Lerman A. Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol. 2003 May 1; 23(5):885-91. Epub 2003 Mar 27.
    View PubMed
  174. Rodriguez-Porcel M, Lerman A, Herrmann J, Schwartz RS, Sawamura T, Condorelli M, Napoli C, Lerman LO. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res. 2003 Apr 1; 58 (1):213-21
    View PubMed
  175. Herrmann J, Edwards WD, Holmes DR Jr, Shogren KL, Lerman LO, Ciechanover A, Lerman A. Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes. J Am Coll Cardiol. 2002 Dec 4; 40 (11):1919-27
    View PubMed
  176. Sternik L, Samee S, Schaff HV, Zehr KJ, Lerman LO, Holmes DR, Holmes DR, Herrmann J, Lerman A. C-reactive protein relaxes human vessels in vitro. Arterioscler Thromb Vasc Biol. 2002 Nov 1; 22 (11):1865-8
    View PubMed
  177. Herrmann J, Lerman A, Baumgart D, Volbracht L, Schulz R, von Birgelen C, Haude M, Heusch G, Erbel R. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation. 2002 Oct 22; 106(17):2180-3.
    View PubMed
  178. Herrmann J, Von Birgelen C, Haude M, Volbracht L, Malyar N, Eggebrecht H, Konorza TF, Baumgart D, Erbel R. Prognostic implication of cardiac troponin T increase following stent implantation. Heart. 2002 Jun; 87(6):549-53.
    View PubMed
  179. Herrmann J, Best PJ, Ritman EL, Holmes DR, Holmes DR, Lerman LO, Lerman A. Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Am Coll Cardiol. 2002 May 1; 39 (9):1555-61
    View PubMed
  180. Wilson SH, Herrmann J, Lerman LO, Holmes DR Jr, Napoli C, Ritman EL, Lerman A. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation. 2002 Jan 29; 105 (4):415-8
    View PubMed
  181. Herrmann J, Haude M, Volbracht L, Altmann C, von Birgelen G, Eggebrecht H, Malyar N, Baumgart D, Mann K, Erbel R. "Rescue" indication for glycoprotein IIb/IIIa receptor inhibition in percutaneous coronary intervention? Intensivmed Notfallmed - German Society of Intensive Care and Emergency Medicine.2002;39:520-8.
  182. Herrmann J, Haude M, Lerman A, Baumgart L, Volbracht L, von Birgelen C, Eggebrecht H, Schmermund A, Erbel R. Hyperemic flow response as an indicator of microembolic events during percutaneous coronary intervention. Circulation.;103()2339-45.
  183. Herrmann J, Lerman LO, Rodriguez-Porcel M, Holmes DR Jr, Rodriguez-Porcel M, Holmes DR Jr, Richardson DM, Ritman EL, Lerman A. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res. 2001 Sep; 51 (4):762-6
    View PubMed
  184. von Birgelen C, Klinkhart W, Mintz GS, Papatheodorou A, Herrmann J, Baumgart D, Haude M, Wieneke H, Ge J, Erbel R. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol. 2001 Jun 1; 37(7):1864-70.
    View PubMed
  185. Herrmann J, Haude M, Lerman A, Schulz R, Volbracht L, Ge J, Schmermund A, Wieneke H, von Birgelen C, Eggebrecht H, Baumgart D, Heusch G, Erbel R. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation. 2001 May 15; 103(19):2339-45.
    View PubMed
  186. Herrmann J, Volbracht L, Haude M, Eggebrecht H, Malyar N, Mann K, Erbel R. [Biochemical markers of ischemic and non-ischemic myocardial damage]. Med Klin (Munich). 2001 Mar 15; 96(3):144-56.
    View PubMed
  187. Herrmann J, Lerman A. The endothelium: dysfunction and beyond. J Nucl Cardiol. 2001 Mar-Apr; 8 (2):197-206
    View PubMed
  188. Sack S, Mouton E, Defaye P, Dagres N, Wolfhard U, Wieneke H, Herrmann J, Oldenburg O, Golles A, Erbel R, AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Asistance. Improved detection and analysis of sensed and paced events in dual chamber pacemakers with extended memory function. A prospective multicenter trial in 626 patients. Herz. 2001 Feb; 26(1):30-9.
    View PubMed
  189. Eggebrecht H, Naber CK, Oldenburg O, Herrmann J, Haude M, Erbel R, Baumgart D. Percutaneous transluminal laser guide wire recanalization of chronic subclavian artery occlusion in symptomatic coronary-subclavian steal syndrome. Catheter Cardiovasc Interv. 2000 Dec; 51(4):500-4.
    View PubMed
  190. Eggebrecht H, Haude M, von Birgelen C, Oldenburg O, Baumgart D, Herrmann J, Welge D, Bartel T, Dagres N, Erbel R. Nonsurgical retrieval of embolized coronary stents. Catheter Cardiovasc Interv. 2000 Dec; 51(4):432-40.
    View PubMed
  191. Oldenburg O, Eggebrecht H, Herrmann J, Naber CK, Haude M, Erbel R, Baumgart D. Dose-dependent effects of intracoronary verapamil on systemic and coronary hemodynamics. Cardiovasc Drugs Ther. 2000 Dec; 14(6):651-5.
    View PubMed
  192. Eggebrecht H, Bruch C, Haude M, Oldenburg O, Herrmann J, von Birgelen C, Hunold P, Baumgart D, Erbel R. [Transluminal exclusion of a subclavian artery aneurysm with stent-graft implantation]. Z Kardiol. 2000 Sep; 89(9):761-5.
    View PubMed
  193. Haude M, Wieneke H, Altmann C, Konorza T, Herrmann J, Eggebrecht H, Erbel R. [Electromechanically controlled versus roengenologically guided percutaneous transluminal laser myocardial revascularization]. Herz. 2000 Sep; 25(6):570-8.
    View PubMed
  194. Eggebrecht H, Oldenburg O, Dirsch O, Haude M, Baumgart D, Welge D, Herrmann J, Arnold G, Schmid KW, Erbel R. Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization:: histological and clinical findings in 7,621 patients. Catheter Cardiovasc Interv. 2000 Apr; 49(4):389-94.
    View PubMed
  195. Eggebrecht H, Haude M, Baumgart D, Oldenburg O, Herrmann J, Bruch C, Hunold P, Neurohr C, von Birgelen C, Welge D, Katz MA, Erbel R. [Hemostatic closure of arterial puncture site using Angio-Seal after diagnostic heart catheterization or coronary intervention]. Herz. 1999 Dec; 24(8):607-13.
    View PubMed
  196. von Birgelen C, Haude M, Herrmann J, Altmann C, Klinkhart W, Welge D, Wieneke H, Baumgart D, Sack S, Erbel R. Early clinical experience with the implantation of a novel synthetic coronary stent graft. Catheter Cardiovasc Interv. 1999 Aug; 47(4):496-503.
    View PubMed
  197. Jeremias A, Kutscher S, Haude M, Heinen D, Baumgart D, Herrmann J, Erbel R. Chest pain after coronary interventional procedures. Incidence and pathophysiology. Herz. 1999 Apr; 24(2):126-31.
    View PubMed
  198. Sack S, Franz R, Dagres N, Oldenburg O, Herrmann J, Golles A, Erbel R. Can right-sided atrioventricular sequential pacing provide benefit for selected patients with severe congestive heart failure? Am J Cardiol. 1999 Mar 11; 83(5B):124D-129D.
    View PubMed
  199. Pfeiffer D, Kimmig R, Herrmann J, Ruge M, Fisseler-Eckhoff A, Scheidel P, Jensen A, Schatz H, Pfeiffer A. Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus. Int J Cancer. 1998 Feb 20; 79(1):49-55.
    View PubMed